Article info
PDFInflamatory bowel disease
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
- Correspondence to Dr G R Greenberg, Mount Sinai Hospital, 445–600 University Avenue, Toronto, Ontario M5G 1X5, Canada; ggreenberg{at}mtsinai.on.ca
Citation
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
Publication history
- Revised May 21, 2009
- Accepted June 23, 2009
- First published August 2, 2009.
Online issue publication
October 26, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd and British Society of Gastroenterology. All rights reserved.